Preliminary explorations of the role of mitochondrial proteins in refractory epilepsy: Some findings from comparative proteomics

Journal of Neuroscience Research

Volumn 85, Issue 14, 2007, Pages 3160-3170

  Jiang, WenJing ^a   Du, BinFeng ^a   Chi, ZhaoFu ^a   Ma, Lin ^a   Wang, ShengJun ^a   Zhang, XuHua ^b   Wu, Wei ^a   Wang, XiaoHua ^a   Xu, GuangRun ^a   Guo, ChunNi ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Epilepsy; Mitochondria; Pharmacoresistance; Proteomics; Rats; Voltage dependent anion channel

Indexed keywords

MITOCHONDRIAL PROTEIN; PHENYTOIN; VOLTAGE DEPENDENT ANION CHANNEL 1; VOLTAGE DEPENDENT ANION CHANNEL 2;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ELECTRON MICROSCOPY; ENERGY; EPILEPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTRACTABLE EPILEPSY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRION; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; ANTICONVULSANTS; DATABASES, FACTUAL; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; EPILEPSY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PHENYTOIN; PROTEOMICS; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 35848970048     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21384     Document Type: Article

References (70)

1. Astrup J, Sorensen PM, Sorensen HR. 1981. Oxygen and glucose consumption related to Na+-K+ transport in canine brain. Stroke 12:726-730.
2. Abu-Hamad S, Sivan S, Shoshan-Barmatz V. 2006. The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc Natl Acad Sci USA 103:5787-5792.
3. Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, Dini G, Janigro D. 2005. RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci 6:61.
4. Baker MA, Ly JD, Lawen A. 2004. Characterization of VDAC1 as a plasma membrane NADH-oxidoreductase. Biofactors 21:215-221.
5. BeltrandelRio H, Wilson J. 1992. Interaction of mitochondrially bound rat brain hexokinase with intramitochondrial compartments of ATP generated by oxidative phosphorylation and creatine kinase. Arch Biochem Biophys 299:116-124.
6. Bidmon HJ, Gorg B, Palomero-Gallagher N, Behne F, Lahl R, Pannek HW, Speckmann EJ, Zilles K. 2004. Heat shock protein-27 is upregulated in the temporal cortex of patients with epilepsy. Epilepsia 45:1549-1559.
7. Boyer PD. 1998. Energy, life, and ATP. Biosci Rep 18:97-117.
8. Bradford MM. 1976. A rapid and sensitive method for the quantification of proteins utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Canafoglia L, Franceschetti S, Antozzi C, Carrara F, Farina L, Granata T, Lamantea E, Savoiardo M, Uziel G, Villani F, Zeviani Z, Avanzini G. 2001. Epileptic phenotype associated with mitochondrial disorders. Neurology 56:1340-1346.
10. Cesar MC, Wilson JE. 2004. All three isoforms of the voltage-dependent anion channel (VDAC1, VDAC2, and VDAC3) are present in mitochondria from bovine, rabbit, and rat brain. Arch Biochem Biophys 422:191-196.
11. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ. 2003. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301:513-517.
12. Chua BT, Volbracht C, Tan KO, Li R, Yu VC, Li P. 2003. Mitochondrial translocation of cofilin is an early step in apoptosis induction. Nat Cell Biol 5:1083-1089.
13. Chuang YC, Chang AY, Lin JW, Hsu SP, Chan SH. 2004. Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat. Epilepsia 45:1202-1209.
14. Cock HR, Tong X, Hargreaves IP, Heales SJ, Clark JB, Patsalos PN, Thom M, Groves M, Schapira AH, Shorvon SD, Walker MC. 2002. Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy Res 48:157-168.
15. Cramer S, Ebert U, Loscher W. 1998. Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: comparison of inbred strains. Epilepsia 39:1046-1053.
16. Crompton M, Virji S, Ward JM. 1998. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem 258:729-735.
17. DiMurro S, Kulikova R, Tanji K, Bonilla E, Hirano M. 1999. Mitochondrial genes for generalized epilepsies. Adv Neurol 79:411-419.
18. Duchen MR. 2000. Mitochondria and calcium: from cell signalling to cell death. J Physiol 529:57-68.
19. Edwin JW, Michael L, Margaret JS, Keltoum A, Dawna LA, Sarah E, Brown JD, Sweatt WJ, Craigen J. 2002. The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. Biol Chem 277:18891-18897.
20. Eun JP, Choi HY, Kwak YG. 2004. Proteomic analysis of human cerebral cortex in epileptic patients. Exp Mol Med 36:185-191.
21. Freeman FG, Jarvis MF. 1981. The effect of interstimulation interval on the assessment and stability of kindled seizure threshold. Brain Res Bull 7:629-633.
22. Fukada K, Zhang F, Vien A, Cashman NR, Zhu H. 2004. Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis. Mol Cell Proteomics 3:1211-1223.
23. Gincel D, Silberberg SD, Shoshan-Barmatz V. 2000. Modulation of the voltage-dependent anion channel (VDAC) by glutamate 1. J Bioenerg Biomembr 32:571-583.
24. Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281:1309-1312.
25. Gupta RC, Dettbarn WD. 2003. Prevention of kainic acid seizures-induced changes in levels of nitric oxide and high-energy phosphates by 7-nitroindazole in rat brain regions. Brain Res 981:184-192.
26. Hellman U, Wernstedt C, Gonez J, Heldin CH. 1995. Improvement of an "In-Gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Anal Biochem 224:451-455.
27. Herrington J, Park YB, Babcock DF, Hille B. 1996. Dominant role of mitochondria in clearance of large Ca2+ loads from rat adrenal chromaffin cells. Neuron 16:219-228.
28. Henshall DC, Clark RS, Adelson PD, Chen M, Watkins SC, Simon RP. 2000. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 55:250-257.
29. Henshall DC, Schindler CK, So NK, Lan JQ, Meller R, Simon RP. 2006. Death-associated protein kinase expression in human temporal lobe epilepsy. Ann Neurol 55:485-494.
30. Johannessen SI, Gran L, Sillanpaa M, Johnson T. 1995. Intractable epilepsy. Petersfield, UK: Wrightson Biomedical Publishing. p 1-12.
31. Jung E, Heller M, Sanchez JC, Hochstrasser DF. 2000. Proteomics meets cell biology: the establishment of subcellular proteomics. Electrophoresis 21:3369-33677.
32. Junker H, Spate K, Suofu Y, Walther R, Schwarz G, Kammer W, Nordheim A, Walker LC, Runqe U, Kessler C, Popa-Wanqner A. 2005. Proteomic identification of the involvement of the mitochondrial rieske protein in epilepsy. Epilepsia 46:339-343.
33. Komarov AG, Deng D, Craigen WJ, Colombini M. 2005. New insights into the mechanism of permeation through large channels. Biophys J 89:3950-3959.
34. Kubota H, Ishihara H, Langmann T, Schmitz G, Stieger B, Wieser HG, Yonekawa Y, Frei K. 2006. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Epilepsy Res 68:213-228.
35. Kunz WS, Kudin AP, Vielhaber S, Blumcke I, Zuschratter W, Schramm J, Beck H, Elger CE. 2000. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 48:766-773.
36. Kwan P, Brodie MJ. 2005. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia 46:224-235.
37. Lai JC, Clark JB. 1979. Preparation of synaptic and nonsynaptic mitochondria from mammalian brain. Methods Enzymol 55:51-60.
38. Lemasters JJ, Holmuhamedov E. 2006. Voltage-dependent anion channel (VDAC) as mitochondrial governator - thinking outside the box. Biochim Biophys Acta 1762:181-190.
39. Leschziner G, Jorgensen AL, Andrew T, Pirmohamed M, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Rogers J, Bentley DR, Chadwick DW, Balding DJ, Johnson MR. 2006. Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study. Lancet Neurol 5:668-676.
40. Liang LP, Ho YS, Patel M. 2000. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 101:563-570.
41. Loscher W. 1997. Animal models of intractable epilepsy. Prog Neurobiol 53:239-258.
42. Loscher W, Reissmuller E, Ebert U. 1998. Anticonvulsant effect of fos-phenytoin in amygdala-kindled rats: comparison with phenytoin. Epilepsy Res 30:69-76.
43. Loscher W, Reissmuller E, Ebert U. 2000. Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats. Epilepsy Res 40:63-77.
44. Marroni M, Agrawal ML, Kight K, Hallen KL, Hossain M, Cucullo L, Signorelli K, Namura S, Bingaman W, Janigro D. 2003. Relationship between expression of multiple drug resistance proteins and p53 tumor suppressor gene proteins in human brain astrocytes. Neuroscience 121:605-617.
45. Miranda E, Lomas DA. 2006. Neuroserpin: a serpin to think about. Cell Mol Life Sci 63:709-722.
46. Racine RJ. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294.
47. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates (4th ed.). Sydney: Academic Press.
48. Remy S, Gabriel S, Urban BW, Dietrich D, Lehmann TN, Elger CE, Heinemann U, Beck H. 2003. A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 53:469-479.
49. Rundfeldt C, Honack D, Loscher W. 1990. Phenytoin potendy increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology 29:845-851.
50. Schatz G. 1995. Mitochondria: beyond oxidative phosphorylation. Biochim Biophys Acta 1271:123-126.
51. Sedlak TW, Snyder SH. 2006. Messenger molecules and cell death: therapeutic implications. JAMA 295:81-89.
52. Shinoda S, Schindler CK, Meller R, So NK, Araki T, Yamamoto A, Lan JQ, Taki W, Simon RP, Henshall DC. 2004. Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy. J Clin Invest 113:1059-1068.
53. Shimizu S, Narita M, Tsujimoto Y. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483-487.
54. Sisodiya SM. 2003. Mechanisms of antiepileptic drug resistance. Curr Opin Neurol 6:197-201.
55. Soontornmalai A, Vlaming ML, Fritschy JM. 2006. Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 138:159-169.
56. Sullivan PG, Dube C, Dorenbos K, Steward O, Baram TZ. 2003. Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann Neurol 53:711-717.
57. Thayer SA, Miller RJ. 1990. Regulation of the intracellular free calcium concentration in single rat dorsal root ganglion neurons in vitro. J Physiol 425:85-115.
58. Tu B, Bazan NG. 2003. Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp Neurol 179:167-175.
59. Urbanska EM. 2000. Seizures evoked by mitochondrial toxin, 3-nitro-propionic acid: new mechanism of epileptogenesis? Pol J Pharmacol 52:55-57.
60. Uysal H, Cevik IU, Soylemezoglu F, Elibol B, Ozdemir YG, Evrenkaya T, Saygi S, Dalkara T. 2003. Is the cell death in mesial temporal sclerosis apoptotic? Epilepsia 44:778-784.
61. Vamecq J, Vallee L, Lesage F, Gressens P, Stables JP. 2005. Antiepileptic popular ketogenic diet: emerging twists in an ancient story. Prog Neurobiol 75:1-28.
62. Van Den Pol AN, Obrietan K, Belousov A. 1996. Glutamate hyperexcitability and seizure-like activity throughout the brain and spinal cord upon relief from chronic glutamate receptor blockade in culture. Neuroscience 74:653-674.
63. Van Vliet EA, van Schaik R, Edelbroek PM, Redeker S, Aronica E, Wadman WJ, Marchi N, Vezzani A, Gorter JA. 2006. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia 47:672-680.
64. Waagepetersen HS, Sonnewald U, Schousboe A. 1999. The GABA paradox: multiple roles as metabolite, neurotransmitter, and neurodifferentiative agent. J Neurochem 73:1335-13342.
65. Yamamoto Y, Schindler CK, Murphy BM, Bellver-Estelles C, So NK, Taki W, Meller R, Simon RP, Henshall DC. 2006. Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsy. Exp Neurol 202:410-420.
66. Yang JW, Czech T, Gelpi E, Lubec G. 2005. Extravasation of plasma proteins can confound interpretation of proteomic studies of brain: a lesson from apo A-1 in mesial temporal lobe epilepsy. Brain Res Mol Brain Res 139:348-356.
67. Yang JW, Czech T, Felizardo M, Baumgartner C, Lubec G. 2006. Aberrant expression of cytoskeleton proteins in hippocampus from patients with mesial temporal lobe epilepsy. Amino Acids 30:477-493.
68. Yegin A, Akbas SH, Ozben T, Korgun DK. 2002. Secretory phospholipase A2 and phospholipids in neural membranes in an experimental epilepsy model. Acta Neurol Scand 106:258-262.
69. Zamzami N, Kroemer G. 2001. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2:67-71.
70. Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJ. 1990. The oxidative inactivation of mitochondrial electron chain components and ATPase. J Biol Chem 265:16330-16336.